These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2982771)

  • 1. Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysis.
    Powell BL; Jackson DV; Scarantino CW; Pope E; Choplin R; Craig JB; Atkins JN; Cooper MR; Hopkins JO; McMahan R
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):457-62. PubMed ID: 2982771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential hemibody irradiation integrated into a chemotherapy-local radiotherapy program for limited disease small cell lung cancer.
    Powell BL; Jackson DV; Scarantino CW; Pope EK; Case LD; Choplin R; Richards F; Muss HB; Craig JB; Cruz JM
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1951-6. PubMed ID: 3021692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemibody radiation, an active therapeutic modality for the management of patients with small cell lung cancer.
    Urtasun RC; Belch A; Bodnar D
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1575-8. PubMed ID: 6313561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiation therapy in the treatment of small cell lung cancer.
    Lichter AS; Bunn PA; Ihde DC; Cohen MH; Makuch RW; Carney DN; Johnston-Early A; Minna JD; Glatstein E
    Cancer; 1985 May; 55(9 Suppl):2163-75. PubMed ID: 2983875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.
    Feld R; Evans WK; DeBoer G; Quirt IC; Shepherd FA; Yeoh JL; Pringle JF; Payne DG; Herman JG; Chamberlain D
    J Clin Oncol; 1984 Apr; 2(4):294-304. PubMed ID: 6323640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper half body irradiation (UHBI) for extensive small cell carcinoma of the lung.
    Payne DG; Yeoh L; Feld R; Pringle JF; Evans WK; Herman JG; Quirt IC
    Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1571-4. PubMed ID: 6313560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer.
    Bonner JA; Eagan RT; Liengswangwong V; Frytak S; Shaw EG; Evans RG; Creagan ET; Richardson RL
    Cancer; 1995 Aug; 76(3):406-12. PubMed ID: 8625121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].
    Yoshida S; Ogata T; Homma T; Kikuchi K; Masuda H; Matsuoka T; Sugiyama K; Noguchi Y; Yoneda S; Fukuda T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2331-6. PubMed ID: 3015041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung.
    Beith JM; Clarke SJ; Woods RL; Bell DR; Levi JA
    Eur J Cancer; 1996 Mar; 32A(3):438-43. PubMed ID: 8814688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer.
    Quon H; Shepherd FA; Payne DG; Coy P; Murray N; Feld R; Pater J; Sadura A; Zee B
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):39-45. PubMed ID: 9989512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
    Souhami RL; Rudd R; Ruiz de Elvira MC; James L; Gower N; Harper PG; Tobias JS; Partridge MR; Davison AG; Trask C
    J Clin Oncol; 1994 Sep; 12(9):1806-13. PubMed ID: 8083704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.
    Park YJ; Koh EH; Kim J; Roh JK; Chang J; Ahn CM; Sohn HY; Kim SK; Lee WY; Kim K
    Yonsei Med J; 1989; 30(1):30-7. PubMed ID: 2545051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.